Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Rheumatoid Arthritis Patients Have More Severe ACS, Poorer Outcomes

Shannon Aymes  |  October 9, 2015

NEW YORK (Reuters Health)—Rheumatoid arthritis (RA) is associated with more-severe acute coronary syndrome and poorer outcomes, according to a new study.

“We found that despite the well-researched increased risk of acute coronary events (ACS) in RA, that there was almost no existing data describing clinical characteristics and outcomes of RA- and non-RA patients with ACS,” Dr. Angla Mantel of Karolinska University Hospital in Stockholm, Sweden, told Reuters Health by email.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Using national registers, Dr. Mantel and colleagues found that 1,135 RA patients (0.9%) and 3,184 matched controls from the general population (0.5%) had incident ACS between 2007 and 2010.

In the patient cohort, stable angina, thromboembolic disease, chronic heart failure and COPD were more prevalent than in the general population, the researchers report in the European Heart Journal, online Sept. 24.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Both groups presented with chest pain about 80% of the time. However, patients with RA demonstrated ST elevations on ECG slightly more often (35.3% vs. 30.5%), had higher troponin levels and more often presented with sudden cardiac death.

RA patients with ST-elevation myocardial infarction (STEMI) received reperfusion therapies such as coronary artery bypass, acute coronary angiography, percutaneous coronary intervention (PCI) or thrombolysis more often the general population group (74.1% vs. 66.2%).

The first week after an ACS event, significantly more RA patients died compared to the controls (10.4% versus 6.7%; adjusted hazard ratio, 1.44).

After 30 days, 15.7% of the RA patients had died versus 10.7% of the controls (adjusted HR, 1.36). In both groups, most of the deaths were attributed to a cardiac cause.

“We hope that our results will lead to a widespread clinical awareness of this group of patients when assessing and (identifying) high-risk ACS patients,” Dr. Mantel said. “We have focused on the clinical importance in this study, but it is also intriguing that our results indicate that the aetiopathology of ACS in RA patients differs from non-RA patients.”

 

Share: 

Filed under:ConditionsRheumatoid Arthritis Tagged with:acute coronary syndromeCardiovascular diseaseMyocardial infarctionOutcomesRheumatoid Arthritis (RA)

Related Articles

    Exploring Kawasaki Disease

    April 2, 2014

    New epidemiologic data, clinical studies have shed light on diagnosis, treatments, patient outcomes for this childhood disease, but etiology is still unknown

    The Heart-SCC Puzzle

    May 1, 2009

    Identifying and treating cardiac involvement in systemic sclerosis can be a challenge

    Coronary Microvascular Dysfunction May Predict Heart Disease in Rheumatoid Arthritis

    December 14, 2020

    AlexLMX / shutterstock.com Cardiovascular disease (CVD) is a leading cause of death in patients with rheumatoid arthritis (RA). Patients with RA have a 1.5 times increased risk for heart attack compared with the general population. Although the treatment of RA has advanced significantly, the ability to prevent cardiovascular events hasn’t followed. A study in Arthritis…

    Myositis & the Heart: New Perspectives on the Pathogenesis & Management of Cardiac Involvement in Myositis

    February 18, 2021

    Experts discuss the diagnosis and treatment of myositis-related cardiovascular disease.

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences